Benoît Fevrier

Crédit Agricole Corporate & Investment Bank SA (Crédit Agricole CIB) is the brokerage subsidiary of Crédit Agricole SA (XP: ACA), ultimately held by Rue de la Boetie SAS in France. Formerly known as Calyon Corporate & Investment Bank SA, created in 2004 by the transfer of Crédit Lyonnais' Corporate and Investment Banking division to Crédit Agricole Indosuez, Crédit Agricole CIB is based in Courbevoie and provides large corporate and institutional clients with a range of products and services through their Coverage and Investment Banking, Equity Brokerage and Derivatives, Fixed Income Markets and Structured Finance divisions.

HSBC Global Asset Management (France) SA (HSBC GAM-France) is the French asset management subsidiary of HSBC Continental Europe, ultimately held by HSBC Holdings Plc (LON: HSBA, ADR: HSBC.PRA) in Great Britain. Formerly HSBC Investments (France) SA, the firm was founded in 1998 within the former CCF-Crédit Commercial de France. Headquartered in Courbevoie with additional office in Puteaux, HSBC GAM-France provides investment advice to banks and thrift institutions, investment companies, pension and profit-sharing plan, corporations, and business entities. They are a socially responsible investor and signatory to the UN Principles for Responsible Investment (UNPRI).

Air Liquide Santé France SA is engaged in supplying medical equipment. The company is headquartered in Paris, France.

Palatine Asset Management SA (PAM) is a mutual fund management firm headquartered in Paris, France. The firm is a subsidiary of Banque Palatine SA, ultimately held by BPCE SA. PAM was founded in 1989 and manages monetary, bonds, fixed-income, and mutual funds for institutional investors, individuals, and companies.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Société Générale Gestion SA (S2G) is the wholly-owned asset management subsidiary of Amundi Asset Management SA, itself a subsidiary of Crédit Agricole SA (EPA: ACA, ADR: CRARY) in France. The firm was founded in 2006 and is headquartered in Paris. They are the successor to SGAM-Société Générale Asset Management SA, founded in 1997 to take over the asset management activities of Société Générale. In 2009 SGAM absorbed their alternative management subsidiary, Barep Asset Management SA. S2G has specific expertise in employee savings plan management and manages discretionary accounts as well as a range of comingled products. Their clients are French companies and institutions, including associations.

Fluofarma provides drug discovery through assay design and high content analysis in cells, blood and tissues. The firm’s services include assay development, cell-based screening, drug profiling and MOA, predictive toxicology, in vivo studies and biomarker analysis. It develops technologies designed for automated flow cytometry, confocal microscopy and laser scanning cytometry. The company was founded by François Ichas and Francesca de Giorgi in 2003 and is headquartered in Pessac, France.